Autoimmune

Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
Immucor's transfusion and transplant product lines complement Werfen's hemostasis, acute care, and autoimmunity business lines, and expand the parent firm's portfolio of specialized diagnostic products for hospitals and clinical laboratories.
March 15, 2023
Business Deal Corporate Social
Prometheus Biosciences announces $500M stock offering
The San Diego-based biotech company is taking a precision medicine approach for the discovery, development, and commercialization of therapeutic and companion diagnostic products for the treatment of immune-mediated diseases.
December 12, 2022
Business Graph Money Stocks Social
CRISPR may enable rapid, sensitive test for COVID-19
The device has the potential for use as a diagnostic test at the point of care (POC), according to its developers.
September 26, 2022
2022 09 23 14 44 4203 Crispr Tiles 400
DxTerity receives NY authorization for SLE test
The DxTerity test is designed for patients with systemic lupus erythema (SLE), which affects up to one million patients in the U.S.
September 15, 2022
2022 09 16 19 12 0006 Test Tubes 400
Aptorum provides update on its rapid MDx technology
The technology has been clinically validated in more than 100 patient samples, Aptorum said.
September 14, 2022
2019 04 24 18 42 4242 Dna Blue 400
Prometheus, Takeda launch prognostic tool for Crohn’s
According to Prometheus, CDPath is a personalized risk assessment tool that can be used in combination with a physician's clinical assessment to evaluate an adult patient's risk for developing serious complications of CD such as bowel strictures, internal penetrating disease, or non-perianal surgery within three years.
September 14, 2022
2021 01 12 23 44 3780 Blood Test Samples Lab 400
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
Patients prefer immediate test results, even when the news is bad
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Nordic touts PRO-C6 biomarker for heart failure clinical trials
In collaboration with Bristol Myers Squibb and the University of Pennsylvania, researchers combined analyses of six independent cohorts of HFpEF patients from around the globe, which are being evaluated with the PRO-C6 biomarker.
September 13, 2022
2022 09 14 21 40 5599 Heart Pulmonary Trunk 400
N-antigen levels point to COVID severity in NIH study
The study by researchers at the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) was a cross-sectional follow-up analysis involving 2,540 participants who had been previously enrolled in the Therapeutics for Inpatients with COVID-19 (TICO) platform trial.
September 8, 2022
2020 03 18 20 13 7386 Virus Coronavirus Covid 19 400
Lunaphore, Nucleai to provide AI-based spatial biology analysis
Combining Lunaphore's Comet hyperplex staining and imaging platform, a fully automated sequential immunofluorescence (seqIF) instrument, with Nucleai's Atom artificial-intelligence (AI) spatial biology platform will enable the companies to generate new insights from tissue biopsies and provide labs with an integrated end-to-end spatial biology workflow.
September 8, 2022
2022 09 09 16 29 7140 Computer Head 400
Week in Review: At-home flu testing, asymptomatic monkeypox, telediagnostic accuracy, and more
Dear LabPulse.com member,
September 7, 2022
IsoPlexis joins MediMergent, CCBD for COVID-19 study
The large multisite study will focus on the functionality of immune cells and their role in prevention of breakthrough COVID-19 infections in immunocompromised patients following administration of AstraZeneca's AZD7442 IM or IV antibody combination.
September 5, 2022
2020 06 17 20 35 0417 Covid 19 Antibody 400
NfL IDs patients predisposed to neurotoxic complications
Analyzing blood samples from patients before, during, and after CAR-T cell therapy, Washington University School of Medicine researchers found that levels of neurofilament light chain (NfL) proteins are higher in patients who develop neurotoxic complications.
August 31, 2022
2022 09 01 15 04 0405 Cancer Therapy Targeted 400
Page 1 of 9
Next Page